<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2002-02-11" modified="2020-10-07" version="213">
<accession>O00206</accession>
<accession>A8K1Y8</accession>
<accession>A9XLP9</accession>
<accession>A9XLQ0</accession>
<accession>A9XLQ1</accession>
<accession>B4E194</accession>
<accession>D1CS52</accession>
<accession>D1CS53</accession>
<accession>Q5VZI8</accession>
<accession>Q5VZI9</accession>
<accession>Q9UK78</accession>
<accession>Q9UM57</accession>
<name>TLR4_HUMAN</name>
<protein>
<recommendedName>
<fullName>Toll-like receptor 4</fullName>
<ecNumber evidence="11">3.2.2.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>hToll</fullName>
</alternativeName>
<cdAntigenName>CD284</cdAntigenName>
</protein>
<gene>
<name type="primary">TLR4</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Nature" volume="388" first="394" last="397">
<title>A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.</title>
<authorList>
<person name="Medzhitov R."/>
<person name="Preston-Hurlburt P."/>
<person name="Janeway C.A. Jr."/>
</authorList>
<dbReference type="PubMed" id="9237759"/>
<dbReference type="DOI" id="10.1038/41131"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="588" last="593">
<title>A family of human receptors structurally related to Drosophila Toll.</title>
<authorList>
<person name="Rock F.L."/>
<person name="Hardiman G."/>
<person name="Timans J.C."/>
<person name="Kastelein R.A."/>
<person name="Bazan J.F."/>
</authorList>
<dbReference type="PubMed" id="9435236"/>
<dbReference type="DOI" id="10.1073/pnas.95.2.588"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Fetal liver</tissue>
<tissue>Lung</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2000" name="Genome Biol." volume="1" first="RESEARCH002.1" last="RESEARCH002.10">
<title>Phylogenetic variation and polymorphism at the Toll-like receptor 4 locus (TLR4).</title>
<authorList>
<person name="Smirnova I."/>
<person name="Poltorak A."/>
<person name="Chan E.K.L."/>
<person name="McBride C."/>
<person name="Beutler B."/>
</authorList>
<dbReference type="PubMed" id="11104518"/>
<dbReference type="DOI" id="10.1186/gb-2000-1-1-research002"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>FUNCTION</scope>
<scope>VARIANTS GLY-299 AND ILE-399</scope>
<scope>CHARACTERIZATION OF VARIANTS GLY-299 AND ILE-399</scope>
<scope>POLYMORPHISM</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2000" name="Nat. Genet." volume="25" first="187" last="191">
<title>TLR4 mutations are associated with endotoxin hyporesponsiveness in humans.</title>
<authorList>
<person name="Arbour N.C."/>
<person name="Lorenz E."/>
<person name="Schutte B.C."/>
<person name="Zabner J."/>
<person name="Kline J.N."/>
<person name="Jones M."/>
<person name="Frees K."/>
<person name="Watt J.L."/>
<person name="Schwartz D.A."/>
</authorList>
<dbReference type="PubMed" id="10835634"/>
<dbReference type="DOI" id="10.1038/76048"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS GLY-299 AND ILE-399</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2008" name="Immunogenetics" volume="60" first="727" last="735">
<title>Natural selection in the TLR-related genes in the course of primate evolution.</title>
<authorList>
<person name="Nakajima T."/>
<person name="Ohtani H."/>
<person name="Satta Y."/>
<person name="Uno Y."/>
<person name="Akari H."/>
<person name="Ishida T."/>
<person name="Kimura A."/>
</authorList>
<dbReference type="PubMed" id="18810425"/>
<dbReference type="DOI" id="10.1007/s00251-008-0332-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2009" name="PLoS ONE" volume="4" first="E7803" last="E7803">
<title>The heterogeneous allelic repertoire of human Toll-Like receptor (TLR) genes.</title>
<authorList>
<person name="Georgel P."/>
<person name="Macquin C."/>
<person name="Bahram S."/>
</authorList>
<dbReference type="PubMed" id="19924287"/>
<dbReference type="DOI" id="10.1371/journal.pone.0007803"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS GLY-299 AND ILE-399</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3)</scope>
<source>
<tissue>Hippocampus</tissue>
<tissue>Kidney</tissue>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Cerebellum</tissue>
</source>
</reference>
<reference key="11">
<citation type="submission" date="2007-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Liu Z."/>
<person name="Li N."/>
<person name="Wang J."/>
<person name="Xiao W."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-86</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Protein Sci." volume="13" first="2819" last="2824">
<title>Signal peptide prediction based on analysis of experimentally verified cleavage sites.</title>
<authorList>
<person name="Zhang Z."/>
<person name="Henzel W.J."/>
</authorList>
<dbReference type="PubMed" id="15340161"/>
<dbReference type="DOI" id="10.1110/ps.04682504"/>
</citation>
<scope>PROTEIN SEQUENCE OF 24-38</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="Nature" volume="408" first="111" last="115">
<title>Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.</title>
<authorList>
<person name="Xu Y."/>
<person name="Tao X."/>
<person name="Shen B."/>
<person name="Horng T."/>
<person name="Medzhitov R."/>
<person name="Manley J.L."/>
<person name="Tong L."/>
</authorList>
<dbReference type="PubMed" id="11081518"/>
<dbReference type="DOI" id="10.1038/35040600"/>
</citation>
<scope>MUTAGENESIS OF GLU-697; ARG-710; ASP-711 AND PRO-714</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="21129" last="21135">
<title>Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2.</title>
<authorList>
<person name="da Silva Correia J."/>
<person name="Soldau K."/>
<person name="Christen U."/>
<person name="Tobias P.S."/>
<person name="Ulevitch R.J."/>
</authorList>
<dbReference type="PubMed" id="11274165"/>
<dbReference type="DOI" id="10.1074/jbc.m009164200"/>
</citation>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="1845" last="1854">
<title>MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor.</title>
<authorList>
<person name="da Silva Correia J."/>
<person name="Ulevitch R.J."/>
</authorList>
<dbReference type="PubMed" id="11706042"/>
<dbReference type="DOI" id="10.1074/jbc.m109910200"/>
</citation>
<scope>GLYCOSYLATION AT ASN-35; ASN-173; ASN-205; ASN-282; ASN-309; ASN-497; ASN-526; ASN-575 AND ASN-624</scope>
<scope>MUTAGENESIS OF ASN-526 AND ASN-575</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="49751" last="49762">
<title>TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta.</title>
<authorList>
<person name="Oshiumi H."/>
<person name="Sasai M."/>
<person name="Shida K."/>
<person name="Fujita T."/>
<person name="Matsumoto M."/>
<person name="Seya T."/>
</authorList>
<dbReference type="PubMed" id="14519765"/>
<dbReference type="DOI" id="10.1074/jbc.m305820200"/>
</citation>
<scope>INTERACTION WITH TICAM2</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="J. Immunol." volume="173" first="3589" last="3593">
<title>Direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B.</title>
<authorList>
<person name="Park H.S."/>
<person name="Jung H.Y."/>
<person name="Park E.Y."/>
<person name="Kim J."/>
<person name="Lee W.J."/>
<person name="Bae Y.S."/>
</authorList>
<dbReference type="PubMed" id="15356101"/>
<dbReference type="DOI" id="10.4049/jimmunol.173.6.3589"/>
</citation>
<scope>INTERACTION WITH NOX4</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="20961" last="20967">
<title>Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals.</title>
<authorList>
<person name="Bulut Y."/>
<person name="Michelsen K.S."/>
<person name="Hayrapetian L."/>
<person name="Naiki Y."/>
<person name="Spallek R."/>
<person name="Singh M."/>
<person name="Arditi M."/>
</authorList>
<dbReference type="PubMed" id="15809303"/>
<dbReference type="DOI" id="10.1074/jbc.m411379200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Infect. Immun." volume="74" first="2686" last="2696">
<title>The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes.</title>
<authorList>
<person name="Jung S.B."/>
<person name="Yang C.S."/>
<person name="Lee J.S."/>
<person name="Shin A.R."/>
<person name="Jung S.S."/>
<person name="Son J.W."/>
<person name="Harding C.V."/>
<person name="Kim H.J."/>
<person name="Park J.K."/>
<person name="Paik T.H."/>
<person name="Song C.H."/>
<person name="Jo E.K."/>
</authorList>
<dbReference type="PubMed" id="16622205"/>
<dbReference type="DOI" id="10.1128/iai.74.5.2686-2696.2006"/>
</citation>
<scope>FUNCTION</scope>
<source>
<tissue>Monocyte</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="Circ. Res." volume="100" first="1589" last="1596">
<title>Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity.</title>
<authorList>
<person name="Kim F."/>
<person name="Pham M."/>
<person name="Luttrell I."/>
<person name="Bannerman D.D."/>
<person name="Tupper J."/>
<person name="Thaler J."/>
<person name="Hawn T.R."/>
<person name="Raines E.W."/>
<person name="Schwartz M.W."/>
</authorList>
<dbReference type="PubMed" id="17478729"/>
<dbReference type="DOI" id="10.1161/circresaha.106.142851"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="Nat. Commun." volume="1" first="79" last="79">
<title>Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperone.</title>
<authorList>
<person name="Liu B."/>
<person name="Yang Y."/>
<person name="Qiu Z."/>
<person name="Staron M."/>
<person name="Hong F."/>
<person name="Li Y."/>
<person name="Wu S."/>
<person name="Li Y."/>
<person name="Hao B."/>
<person name="Bona R."/>
<person name="Han D."/>
<person name="Li Z."/>
</authorList>
<dbReference type="PubMed" id="20865800"/>
<dbReference type="DOI" id="10.1038/ncomms1070"/>
</citation>
<scope>INTERACTION WITH HSP90B1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2012" name="Nat. Commun." volume="3" first="653" last="653">
<authorList>
<person name="Liu B."/>
<person name="Yang Y."/>
<person name="Qiu Z."/>
<person name="Staron M."/>
<person name="Hong F."/>
<person name="Li Y."/>
<person name="Wu S."/>
<person name="Li Y."/>
<person name="Hao B."/>
<person name="Bona R."/>
<person name="Han D."/>
<person name="Li Z."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:20865800</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="Nat. Immunol." volume="11" first="155" last="161">
<title>CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer.</title>
<authorList>
<person name="Stewart C.R."/>
<person name="Stuart L.M."/>
<person name="Wilkinson K."/>
<person name="van Gils J.M."/>
<person name="Deng J."/>
<person name="Halle A."/>
<person name="Rayner K.J."/>
<person name="Boyer L."/>
<person name="Zhong R."/>
<person name="Frazier W.A."/>
<person name="Lacy-Hulbert A."/>
<person name="El Khoury J."/>
<person name="Golenbock D.T."/>
<person name="Moore K.J."/>
</authorList>
<dbReference type="PubMed" id="20037584"/>
<dbReference type="DOI" id="10.1038/ni.1836"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CD36 AND TLR6</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="Nat. Immunol." volume="11" first="814" last="819">
<title>Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel.</title>
<authorList>
<person name="Schmidt M."/>
<person name="Raghavan B."/>
<person name="Mueller V."/>
<person name="Vogl T."/>
<person name="Fejer G."/>
<person name="Tchaptchet S."/>
<person name="Keck S."/>
<person name="Kalis C."/>
<person name="Nielsen P.J."/>
<person name="Galanos C."/>
<person name="Roth J."/>
<person name="Skerra A."/>
<person name="Martin S.F."/>
<person name="Freudenberg M.A."/>
<person name="Goebeler M."/>
</authorList>
<dbReference type="PubMed" id="20711192"/>
<dbReference type="DOI" id="10.1038/ni.1919"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF HIS-431; HIS-456 AND HIS-458</scope>
<scope>INVOLVEMENT IN CONTACT ALLERGY TO NICKEL</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2012" name="Cell. Mol. Immunol." volume="9" first="27" last="33">
<title>MLK4 has negative effect on TLR4 signaling.</title>
<authorList>
<person name="Seit-Nebi A."/>
<person name="Cheng W."/>
<person name="Xu H."/>
<person name="Han J."/>
</authorList>
<dbReference type="PubMed" id="21602844"/>
<dbReference type="DOI" id="10.1038/cmi.2011.15"/>
</citation>
<scope>INTERACTION WITH MAP3K21</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2013" name="Atherosclerosis" volume="229" first="356" last="362">
<title>CD14 and TLR4 mediate cytokine release promoted by electronegative LDL in monocytes.</title>
<authorList>
<person name="Estruch M."/>
<person name="Bancells C."/>
<person name="Beloki L."/>
<person name="Sanchez-Quesada J.L."/>
<person name="Ordonez-Llanos J."/>
<person name="Benitez S."/>
</authorList>
<dbReference type="PubMed" id="23880187"/>
<dbReference type="DOI" id="10.1016/j.atherosclerosis.2013.05.011"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2013" name="Proc. Natl. Acad. Sci. U.S.A." volume="110" first="6985" last="6990">
<title>Molecular mechanisms for the subversion of MyD88 signaling by TcpC from virulent uropathogenic Escherichia coli.</title>
<authorList>
<person name="Snyder G.A."/>
<person name="Cirl C."/>
<person name="Jiang J."/>
<person name="Chen K."/>
<person name="Waldhuber A."/>
<person name="Smith P."/>
<person name="Roemmler F."/>
<person name="Snyder N."/>
<person name="Fresquez T."/>
<person name="Duerr S."/>
<person name="Tjandra N."/>
<person name="Miethke T."/>
<person name="Xiao T.S."/>
</authorList>
<dbReference type="PubMed" id="23569230"/>
<dbReference type="DOI" id="10.1073/pnas.1215770110"/>
</citation>
<scope>INTERACTION WITH E.COLI PROTEIN TCPC (MICROBIAL INFECTION)</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2015" name="EMBO Rep." volume="16" first="447" last="455">
<title>WDFY1 mediates TLR3/4 signaling by recruiting TRIF.</title>
<authorList>
<person name="Hu Y.H."/>
<person name="Zhang Y."/>
<person name="Jiang L.Q."/>
<person name="Wang S."/>
<person name="Lei C.Q."/>
<person name="Sun M.S."/>
<person name="Shu H.B."/>
<person name="Liu Y."/>
</authorList>
<dbReference type="PubMed" id="25736436"/>
<dbReference type="DOI" id="10.15252/embr.201439637"/>
</citation>
<scope>INTERACTION WITH TICAM1 AND TICAM2</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2016" name="J. Immunol." volume="196" first="3865" last="3876">
<title>Raftlin controls lipopolysaccharide-induced TLR4 internalization and TICAM-1 signaling in a cell type-specific manner.</title>
<authorList>
<person name="Tatematsu M."/>
<person name="Yoshida R."/>
<person name="Morioka Y."/>
<person name="Ishii N."/>
<person name="Funami K."/>
<person name="Watanabe A."/>
<person name="Saeki K."/>
<person name="Seya T."/>
<person name="Matsumoto M."/>
</authorList>
<dbReference type="PubMed" id="27022195"/>
<dbReference type="DOI" id="10.4049/jimmunol.1501734"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RFTN1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION BY LPS</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2007" name="Cell" volume="130" first="906" last="917">
<title>Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.</title>
<authorList>
<person name="Kim H.M."/>
<person name="Park B.S."/>
<person name="Kim J.-I."/>
<person name="Kim S.E."/>
<person name="Lee J."/>
<person name="Oh S.C."/>
<person name="Enkhbayar P."/>
<person name="Matsushima N."/>
<person name="Lee H."/>
<person name="Yoo O.J."/>
<person name="Lee J.-O."/>
</authorList>
<dbReference type="PubMed" id="17803912"/>
<dbReference type="DOI" id="10.1016/j.cell.2007.08.002"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 27-228 IN COMPLEX WITH LY96</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-35; ASN-173 AND ASN-205</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="Nature" volume="458" first="1191" last="1195">
<title>The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex.</title>
<authorList>
<person name="Park B.S."/>
<person name="Song D.H."/>
<person name="Kim H.M."/>
<person name="Choi B.-S."/>
<person name="Lee H."/>
<person name="Lee J.-O."/>
</authorList>
<dbReference type="PubMed" id="19252480"/>
<dbReference type="DOI" id="10.1038/nature07830"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 27-631 IN COMPLEX WITH LY96 AND LIPOPOLYSACCHARIDE</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-173; ASN-205; ASN-497 AND ASN-526 AND ASN-575</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E30929" last="E30929">
<title>Structure-based rational design of a Toll-like receptor 4 (TLR4) decoy receptor with high binding affinity for a target protein.</title>
<authorList>
<person name="Han J."/>
<person name="Kim H.J."/>
<person name="Lee S.C."/>
<person name="Hong S."/>
<person name="Park K."/>
<person name="Jeon Y.H."/>
<person name="Kim D."/>
<person name="Cheong H.K."/>
<person name="Kim H.S."/>
</authorList>
<dbReference type="PubMed" id="22363519"/>
<dbReference type="DOI" id="10.1371/journal.pone.0030929"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.37 ANGSTROMS) OF 28-228</scope>
<scope>GLYCOSYLATION AT ASN-35 AND ASN-173</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2001" name="Genetics" volume="158" first="1657" last="1664">
<title>Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans.</title>
<authorList>
<person name="Smirnova I."/>
<person name="Hamblin M.T."/>
<person name="McBride C."/>
<person name="Beutler B."/>
<person name="Di Rienzo A."/>
</authorList>
<dbReference type="PubMed" id="11514453"/>
</citation>
<scope>VARIANTS ARG-188; SER-246; GLY-299; SER-329; ILE-399; LEU-443; LYS-474; HIS-510; ARG-694; HIS-763 AND HIS-834</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2005" name="Hum. Mol. Genet." volume="14" first="1449" last="1455">
<title>Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration.</title>
<authorList>
<person name="Zareparsi S."/>
<person name="Buraczynska M."/>
<person name="Branham K.E.H."/>
<person name="Shah S."/>
<person name="Eng D."/>
<person name="Li M."/>
<person name="Pawar H."/>
<person name="Yashar B.M."/>
<person name="Moroi S.E."/>
<person name="Lichter P.R."/>
<person name="Petty H.R."/>
<person name="Richards J.E."/>
<person name="Abecasis G.R."/>
<person name="Elner V.M."/>
<person name="Swaroop A."/>
</authorList>
<dbReference type="PubMed" id="15829498"/>
<dbReference type="DOI" id="10.1093/hmg/ddi154"/>
</citation>
<scope>VARIANT GLY-299</scope>
<scope>ASSOCIATION WITH ARMD SUSCEPTIBILITY</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2015" name="Proc. Natl. Acad. Sci. U.S.A." volume="112" first="4062" last="4067">
<title>Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas.</title>
<authorList>
<person name="Cromer M.K."/>
<person name="Choi M."/>
<person name="Nelson-Williams C."/>
<person name="Fonseca A.L."/>
<person name="Kunstman J.W."/>
<person name="Korah R.M."/>
<person name="Overton J.D."/>
<person name="Mane S."/>
<person name="Kenney B."/>
<person name="Malchoff C.D."/>
<person name="Stalberg P."/>
<person name="Akerstroem G."/>
<person name="Westin G."/>
<person name="Hellman P."/>
<person name="Carling T."/>
<person name="Bjoerklund P."/>
<person name="Lifton R.P."/>
</authorList>
<dbReference type="PubMed" id="25787250"/>
<dbReference type="DOI" id="10.1073/pnas.1503696112"/>
</citation>
<scope>VARIANT ASP-287</scope>
</reference>
<comment type="function">
<text evidence="12 21 23 24 28 29 34 37 38">Cooperates with LY96 and CD14 to mediate the innate immune response to bacterial lipopolysaccharide (LPS) (PubMed:27022195). Acts via MYD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed:9237759, PubMed:10835634, PubMed:27022195). Also involved in LPS-independent inflammatory responses triggered by free fatty acids, such as palmitate, and Ni(2+). Responses triggered by Ni(2+) require non-conserved histidines and are, therefore, species-specific (PubMed:20711192). Both M.tuberculosis HSP70 (dnaK) and HSP65 (groEL-2) act via this protein to stimulate NF-kappa-B expression (PubMed:15809303). In complex with TLR6, promotes sterile inflammation in monocytes/macrophages in response to oxidized low-density lipoprotein (oxLDL) or amyloid-beta 42. In this context, the initial signal is provided by oxLDL- or amyloid-beta 42-binding to CD36. This event induces the formation of a heterodimer of TLR4 and TLR6, which is rapidly internalized and triggers inflammatory response, leading to the NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway, as well as IL1B secretion. Binds electronegative LDL (LDL(-)) and mediates the cytokine release induced by LDL(-) (PubMed:23880187). Stimulation of monocytes in vitro with M.tuberculosis PstS1 induces p38 MAPK and ERK1/2 activation primarily via TLR2, but also partially via this receptor (PubMed:16622205).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="11">
<text>H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:16301"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57967"/>
<dbReference type="EC" id="3.2.2.6"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="11">
<dbReference type="Rhea" id="RHEA:16302"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="9 15 18 20 25 26 28 30 31 35 37">Belongs to the lipopolysaccharide (LPS) receptor, a multi-protein complex containing at least CD14, LY96 and TLR4 (PubMed:11274165). Binding to bacterial LPS leads to homodimerization. Interacts with LY96 via the extracellular domain (PubMed:17803912, PubMed:19252480). Interacts with MYD88 and TIRAP via their respective TIR domains (By similarity). Interacts with TICAM2 (PubMed:14519765, PubMed:25736436). Interacts with NOX4 (PubMed:15356101). Interacts with CNPY3 (By similarity). Interacts with HSP90B1. The interaction with both CNPY3 and HSP90B1 is required for proper folding in the endoplasmic reticulum. Interacts with MAP3K21; this interaction leads to negative regulation of TLR4 signaling (PubMed:21602844). Interacts with CD36, following CD36 stimulation by oxLDL or amyloid-beta 42, and forms a heterodimer with TLR6 (PubMed:20037584). The trimeric complex is internalized and triggers inflammatory response. LYN kinase activity facilitates TLR4-TLR6 heterodimerization and signal initiation. Interacts with TICAM1 in response to LPS in a WDFY1-dependent manner (PubMed:25736436). Interacts with WDFY1 in response to LPS (By similarity). Interacts with SMPDL3B (By similarity). Interacts with CEACAM1; upon lipopolysaccharide stimulation, forms a complex including TLR4 and the phosphorylated form of SYK and CEACAM1, which in turn, recruits PTPN6 that dephosphorylates SYK, reducing the production of reactive oxygen species (ROS) and lysosome disruption, which in turn, reduces the activity of the inflammasome (By similarity). Interacts with RFTN1; the interaction occurs in response to lipopolysaccharide stimulation (PubMed:27022195). Interacts with SCIMP; the interaction occurs in response to lipopolysaccharide stimulation and is enhanced by phosphorylation of SCIMP by LYN (By similarity). This interaction facilitates the phosphorylation of TLR4 by LYN which elicits a selective cytokine response in macrophages (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="33">(Microbial infection) In case of infection, interacts with uropathogenic E.coli protein TcpC.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-528701">
<id>O00206</id>
</interactant>
<interactant intactId="EBI-389432">
<id>P09429</id>
<label>HMGB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-528701">
<id>O00206</id>
</interactant>
<interactant intactId="EBI-1539247">
<id>Q9Y6Y9</id>
<label>LY96</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-528701">
<id>O00206</id>
</interactant>
<interactant intactId="EBI-447677">
<id>Q99836</id>
<label>MYD88</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-528701">
<id>O00206</id>
</interactant>
<interactant intactId="EBI-11301574">
<id>Q9NPH5</id>
<label>NOX4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-528701">
<id>O00206</id>
</interactant>
<interactant intactId="EBI-750381">
<id>O15389</id>
<label>SIGLEC5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-528701">
<id>O00206</id>
</interactant>
<interactant intactId="EBI-12161783">
<id>O43699-3</id>
<label>SIGLEC6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-528701">
<id>O00206</id>
</interactant>
<interactant intactId="EBI-12857926">
<id>Q9Y336</id>
<label>SIGLEC9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-528701">
<id>O00206</id>
</interactant>
<interactant intactId="EBI-525927">
<id>Q86XR7</id>
<label>TICAM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-528701">
<id>O00206</id>
</interactant>
<interactant intactId="EBI-528644">
<id>P58753</id>
<label>TIRAP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-528701">
<id>O00206</id>
</interactant>
<interactant intactId="EBI-528701">
<id>O00206</id>
<label>TLR4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-528701">
<id>O00206</id>
</interactant>
<interactant intactId="EBI-13940779">
<id>Q9Y2C9</id>
<label>TLR6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-528701">
<id>O00206</id>
</interactant>
<interactant intactId="EBI-9979894">
<id>P24821</id>
<label>TNC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15745059">
<id>O00206-1</id>
</interactant>
<interactant intactId="EBI-1539247">
<id>Q9Y6Y9</id>
<label>LY96</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15745059">
<id>O00206-1</id>
</interactant>
<interactant intactId="EBI-15745025">
<id>P49278</id>
<label>DERP2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="15 28 37 38">Cell membrane</location>
<topology evidence="15">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="37">Early endosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Cell projection</location>
<location evidence="9">Ruffle</location>
</subcellularLocation>
<text evidence="28">Upon complex formation with CD36 and TLR6, internalized through dynamin-dependent endocytosis (PubMed:20037584). Colocalizes with RFTN1 at cell membrane and then together with RFTN1 moves to endosomes, upon lipopolysaccharide stimulation.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O00206-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O00206-2</id>
<name>2</name>
<sequence type="described" ref="VSP_035794"/>
</isoform>
<isoform>
<id>O00206-3</id>
<name>3</name>
<sequence type="described" ref="VSP_035793"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="37 38 39">Highly expressed in placenta, spleen and peripheral blood leukocytes (PubMed:9435236, PubMed:9237759). Detected in monocytes, macrophages, dendritic cells and several types of T-cells (PubMed:9237759, PubMed:27022195).</text>
</comment>
<comment type="domain">
<text evidence="20">The TIR domain mediates interaction with NOX4.</text>
</comment>
<comment type="domain">
<text evidence="11">The TIR domain mediates NAD(+) hydrolase (NADase) activity. Self-association of TIR domains is required for NADase activity.</text>
</comment>
<comment type="PTM">
<text evidence="17 25 26 32">N-glycosylated. Glycosylation of Asn-526 and Asn-575 seems to be necessary for the expression of TLR4 on the cell surface and the LPS-response. Likewise, mutants lacking two or more of the other N-glycosylation sites were deficient in interaction with LPS.</text>
</comment>
<comment type="PTM">
<text evidence="9">Phosphorylated on tyrosine residues by LYN after binding lipopolysaccharide.</text>
</comment>
<comment type="polymorphism">
<text evidence="12">Allele TLR4*B (Gly-299, Ile-399) is associated with a blunted response to inhaled LPS.</text>
</comment>
<comment type="miscellaneous">
<text evidence="43">His-456 and His-458 are found in TLR4 of human and several other primate species and may be responsible for inflammatory responses triggered by nickel (Ni(2+)). Ni(2+) may cross-link the two receptor monomers through specific histidines, triggering the formation of a dimer that structurally resembles that induced by LPS. This process may be the basis for the development of contact allergy to Ni(2+). A mouse model of contact allergy to Ni(2+) in which TLR4-deficient mice expresses human TLR4 has been proposed.</text>
</comment>
<comment type="similarity">
<text evidence="42">Belongs to the Toll-like receptor family.</text>
</comment>
<comment type="online information" name="Protein Spotlight">
<link uri="https://web.expasy.org/spotlight/back_issues/134"/>
<text>Zips, necklaces and mobile telephones - Issue 134 of December 2011</text>
</comment>
<dbReference type="EC" id="3.2.2.6" evidence="11"/>
<dbReference type="EMBL" id="U93091">
<property type="protein sequence ID" value="AAC80227.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB445638">
<property type="protein sequence ID" value="BAG55035.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ018107">
<property type="protein sequence ID" value="AAY82267.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ018108">
<property type="protein sequence ID" value="AAY82268.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ018109">
<property type="protein sequence ID" value="AAY82269.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290053">
<property type="protein sequence ID" value="BAF82742.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK293068">
<property type="protein sequence ID" value="BAF85757.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK303730">
<property type="protein sequence ID" value="BAG64706.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL160272">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471090">
<property type="protein sequence ID" value="EAW87448.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471090">
<property type="protein sequence ID" value="EAW87451.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC117422">
<property type="protein sequence ID" value="AAI17423.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF535831">
<property type="protein sequence ID" value="ABU41662.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EF535832">
<property type="protein sequence ID" value="ABU41663.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EF535833">
<property type="protein sequence ID" value="ABU41664.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF177765">
<property type="protein sequence ID" value="AAF05316.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF177766">
<property type="protein sequence ID" value="AAF07823.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF172171">
<property type="protein sequence ID" value="AAF89753.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF172169">
<property type="protein sequence ID" value="AAF89753.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF172170">
<property type="protein sequence ID" value="AAF89753.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U88880">
<property type="protein sequence ID" value="AAC34135.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6818.1">
<molecule id="O00206-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003257.1">
<molecule id="O00206-2"/>
<property type="nucleotide sequence ID" value="NM_003266.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_612564.1">
<molecule id="O00206-1"/>
<property type="nucleotide sequence ID" value="NM_138554.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_612567.1">
<molecule id="O00206-3"/>
<property type="nucleotide sequence ID" value="NM_138557.2"/>
</dbReference>
<dbReference type="PDB" id="2Z62">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=27-228"/>
</dbReference>
<dbReference type="PDB" id="2Z63">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=27-527"/>
</dbReference>
<dbReference type="PDB" id="2Z65">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=27-228"/>
</dbReference>
<dbReference type="PDB" id="2Z66">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B/C/D=381-627"/>
</dbReference>
<dbReference type="PDB" id="3FXI">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B=27-631"/>
</dbReference>
<dbReference type="PDB" id="3UL7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.37"/>
<property type="chains" value="A=28-226"/>
</dbReference>
<dbReference type="PDB" id="3UL8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=27-228"/>
</dbReference>
<dbReference type="PDB" id="3UL9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A=28-228"/>
</dbReference>
<dbReference type="PDB" id="3ULA">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="A/C=27-228"/>
</dbReference>
<dbReference type="PDB" id="4G8A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=23-629"/>
</dbReference>
<dbReference type="PDB" id="5NAM">
<property type="method" value="NMR"/>
<property type="chains" value="A=623-670"/>
</dbReference>
<dbReference type="PDB" id="5NAO">
<property type="method" value="NMR"/>
<property type="chains" value="A=623-657"/>
</dbReference>
<dbReference type="PDBsum" id="2Z62"/>
<dbReference type="PDBsum" id="2Z63"/>
<dbReference type="PDBsum" id="2Z65"/>
<dbReference type="PDBsum" id="2Z66"/>
<dbReference type="PDBsum" id="3FXI"/>
<dbReference type="PDBsum" id="3UL7"/>
<dbReference type="PDBsum" id="3UL8"/>
<dbReference type="PDBsum" id="3UL9"/>
<dbReference type="PDBsum" id="3ULA"/>
<dbReference type="PDBsum" id="4G8A"/>
<dbReference type="PDBsum" id="5NAM"/>
<dbReference type="PDBsum" id="5NAO"/>
<dbReference type="SMR" id="O00206"/>
<dbReference type="BioGRID" id="112954">
<property type="interactions" value="36"/>
</dbReference>
<dbReference type="CORUM" id="O00206"/>
<dbReference type="DIP" id="DIP-34769N"/>
<dbReference type="ELM" id="O00206"/>
<dbReference type="IntAct" id="O00206">
<property type="interactions" value="31"/>
</dbReference>
<dbReference type="MINT" id="O00206"/>
<dbReference type="STRING" id="9606.ENSP00000363089"/>
<dbReference type="BindingDB" id="O00206"/>
<dbReference type="ChEMBL" id="CHEMBL5255"/>
<dbReference type="DrugBank" id="DB02767">
<property type="generic name" value="(R)-3-hydroxytetradecanoic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00924">
<property type="generic name" value="Cyclobenzaprine"/>
</dbReference>
<dbReference type="DrugBank" id="DB06447">
<property type="generic name" value="E5531"/>
</dbReference>
<dbReference type="DrugBank" id="DB04933">
<property type="generic name" value="Eritoran"/>
</dbReference>
<dbReference type="DrugBank" id="DB05475">
<property type="generic name" value="Golotimod"/>
</dbReference>
<dbReference type="DrugBank" id="DB03017">
<property type="generic name" value="Lauric acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB13615">
<property type="generic name" value="Mifamurtide"/>
</dbReference>
<dbReference type="DrugBank" id="DB08231">
<property type="generic name" value="Myristic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01183">
<property type="generic name" value="Naloxone"/>
</dbReference>
<dbReference type="DrugBank" id="DB11193">
<property type="generic name" value="Papain"/>
</dbReference>
<dbReference type="DrugCentral" id="O00206"/>
<dbReference type="TCDB" id="8.A.43.1.9">
<property type="family name" value="the neat-domain containing methaemoglobin heme sequestration (n-mhs) family"/>
</dbReference>
<dbReference type="GlyGen" id="O00206">
<property type="glycosylation" value="10 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="O00206"/>
<dbReference type="PhosphoSitePlus" id="O00206"/>
<dbReference type="BioMuta" id="TLR4"/>
<dbReference type="MassIVE" id="O00206"/>
<dbReference type="PaxDb" id="O00206"/>
<dbReference type="PeptideAtlas" id="O00206"/>
<dbReference type="PRIDE" id="O00206"/>
<dbReference type="ProteomicsDB" id="47779">
<molecule id="O00206-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="47780">
<molecule id="O00206-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="47781">
<molecule id="O00206-3"/>
</dbReference>
<dbReference type="ABCD" id="O00206">
<property type="antibodies" value="21 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="3410">
<property type="antibodies" value="1819 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000355622">
<molecule id="O00206-1"/>
<property type="protein sequence ID" value="ENSP00000363089"/>
<property type="gene ID" value="ENSG00000136869"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000394487">
<molecule id="O00206-2"/>
<property type="protein sequence ID" value="ENSP00000377997"/>
<property type="gene ID" value="ENSG00000136869"/>
</dbReference>
<dbReference type="GeneID" id="7099"/>
<dbReference type="KEGG" id="hsa:7099"/>
<dbReference type="UCSC" id="uc004bjz.5">
<molecule id="O00206-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7099"/>
<dbReference type="DisGeNET" id="7099"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000136869.13"/>
<dbReference type="GeneCards" id="TLR4"/>
<dbReference type="HGNC" id="HGNC:11850">
<property type="gene designation" value="TLR4"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000136869">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="TLR4"/>
<dbReference type="MIM" id="603030">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O00206"/>
<dbReference type="OpenTargets" id="ENSG00000136869"/>
<dbReference type="Orphanet" id="117">
<property type="disease" value="Behcet disease"/>
</dbReference>
<dbReference type="PharmGKB" id="PA36552"/>
<dbReference type="eggNOG" id="KOG4641">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000160778"/>
<dbReference type="HOGENOM" id="CLU_006000_5_0_1"/>
<dbReference type="InParanoid" id="O00206"/>
<dbReference type="KO" id="K10160"/>
<dbReference type="OMA" id="AHNLIHS"/>
<dbReference type="OrthoDB" id="282372at2759"/>
<dbReference type="PhylomeDB" id="O00206"/>
<dbReference type="TreeFam" id="TF351113"/>
<dbReference type="PathwayCommons" id="O00206"/>
<dbReference type="Reactome" id="R-HSA-1236974">
<property type="pathway name" value="ER-Phagosome pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-140534">
<property type="pathway name" value="Caspase activation via Death Receptors in the presence of ligand"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-166016">
<property type="pathway name" value="Toll Like Receptor 4 (TLR4) Cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-166058">
<property type="pathway name" value="MyD88:MAL(TIRAP) cascade initiated on plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-166166">
<property type="pathway name" value="MyD88-independent TLR4 cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2562578">
<property type="pathway name" value="TRIF-mediated programmed cell death"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5602498">
<property type="pathway name" value="MyD88 deficiency (TLR2/4)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5603041">
<property type="pathway name" value="IRAK4 deficiency (TLR2/4)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5686938">
<property type="pathway name" value="Regulation of TLR by endogenous ligand"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-936964">
<property type="pathway name" value="Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-937041">
<property type="pathway name" value="IKK complex recruitment mediated by RIP1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-937072">
<property type="pathway name" value="TRAF6-mediated induction of TAK1 complex within TLR4 complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975163">
<property type="pathway name" value="IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation"/>
</dbReference>
<dbReference type="SignaLink" id="O00206"/>
<dbReference type="SIGNOR" id="O00206"/>
<dbReference type="BioGRID-ORCS" id="7099">
<property type="hits" value="2 hits in 871 CRISPR screens"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O00206"/>
<dbReference type="GeneWiki" id="TLR_4"/>
<dbReference type="GenomeRNAi" id="7099"/>
<dbReference type="Pharos" id="O00206">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:O00206"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="RNAct" id="O00206">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000136869">
<property type="expression patterns" value="Expressed in leukocyte and 198 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O00206">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O00206">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005769">
<property type="term" value="C:early endosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031226">
<property type="term" value="C:intrinsic component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046696">
<property type="term" value="C:lipopolysaccharide receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001891">
<property type="term" value="C:phagocytic cup"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001726">
<property type="term" value="C:ruffle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0001540">
<property type="term" value="F:amyloid-beta binding"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0001530">
<property type="term" value="F:lipopolysaccharide binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001875">
<property type="term" value="F:lipopolysaccharide immune receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050135">
<property type="term" value="F:NAD(P)+ nucleosidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0061809">
<property type="term" value="F:NAD+ nucleotidase, cyclic ADP-ribose generating"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:signaling receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002218">
<property type="term" value="P:activation of innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000187">
<property type="term" value="P:activation of MAPK activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097190">
<property type="term" value="P:apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0014002">
<property type="term" value="P:astrocyte development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002322">
<property type="term" value="P:B cell proliferation involved in immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904646">
<property type="term" value="P:cellular response to amyloid-beta"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071346">
<property type="term" value="P:cellular response to interferon-gamma"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071222">
<property type="term" value="P:cellular response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071223">
<property type="term" value="P:cellular response to lipoteichoic acid"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071260">
<property type="term" value="P:cellular response to mechanical stimulus"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0140052">
<property type="term" value="P:cellular response to oxidised low-density lipoprotein particle stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042742">
<property type="term" value="P:defense response to bacterium"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050829">
<property type="term" value="P:defense response to Gram-negative bacterium"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016046">
<property type="term" value="P:detection of fungus"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032497">
<property type="term" value="P:detection of lipopolysaccharide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007249">
<property type="term" value="P:I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007252">
<property type="term" value="P:I-kappaB phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032609">
<property type="term" value="P:interferon-gamma production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032611">
<property type="term" value="P:interleukin-1 beta production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060729">
<property type="term" value="P:intestinal epithelial structure maintenance"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031663">
<property type="term" value="P:lipopolysaccharide-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042116">
<property type="term" value="P:macrophage activation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002756">
<property type="term" value="P:MyD88-independent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070266">
<property type="term" value="P:necroptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0120163">
<property type="term" value="P:negative regulation of cold-induced thermogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="YuBioLab"/>
</dbReference>
<dbReference type="GO" id="GO:0070373">
<property type="term" value="P:negative regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032689">
<property type="term" value="P:negative regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032700">
<property type="term" value="P:negative regulation of interleukin-17 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032707">
<property type="term" value="P:negative regulation of interleukin-23 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032715">
<property type="term" value="P:negative regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034128">
<property type="term" value="P:negative regulation of MyD88-independent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045671">
<property type="term" value="P:negative regulation of osteoclast differentiation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032720">
<property type="term" value="P:negative regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002537">
<property type="term" value="P:nitric oxide production involved in inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006909">
<property type="term" value="P:phagocytosis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030890">
<property type="term" value="P:positive regulation of B cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1903974">
<property type="term" value="P:positive regulation of cellular response to macrophage colony-stimulating factor stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000343">
<property type="term" value="P:positive regulation of chemokine (C-X-C motif) ligand 2 production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032722">
<property type="term" value="P:positive regulation of chemokine production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900017">
<property type="term" value="P:positive regulation of cytokine production involved in inflammatory response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032727">
<property type="term" value="P:positive regulation of interferon-alpha production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032728">
<property type="term" value="P:positive regulation of interferon-beta production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032729">
<property type="term" value="P:positive regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032731">
<property type="term" value="P:positive regulation of interleukin-1 beta production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032732">
<property type="term" value="P:positive regulation of interleukin-1 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032733">
<property type="term" value="P:positive regulation of interleukin-10 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032735">
<property type="term" value="P:positive regulation of interleukin-12 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032757">
<property type="term" value="P:positive regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046330">
<property type="term" value="P:positive regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010838">
<property type="term" value="P:positive regulation of keratinocyte proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043032">
<property type="term" value="P:positive regulation of macrophage activation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060907">
<property type="term" value="P:positive regulation of macrophage cytokine production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904466">
<property type="term" value="P:positive regulation of matrix metallopeptidase secretion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045348">
<property type="term" value="P:positive regulation of MHC class II biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:1901224">
<property type="term" value="P:positive regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045429">
<property type="term" value="P:positive regulation of nitric oxide biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051770">
<property type="term" value="P:positive regulation of nitric-oxide synthase biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900227">
<property type="term" value="P:positive regulation of NLRP3 inflammasome complex assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070430">
<property type="term" value="P:positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070434">
<property type="term" value="P:positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1903223">
<property type="term" value="P:positive regulation of oxidative stress-induced neuron death"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010572">
<property type="term" value="P:positive regulation of platelet activation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903428">
<property type="term" value="P:positive regulation of reactive oxygen species biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042535">
<property type="term" value="P:positive regulation of tumor necrosis factor biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032760">
<property type="term" value="P:positive regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002730">
<property type="term" value="P:regulation of dendritic cell cytokine production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032496">
<property type="term" value="P:response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042088">
<property type="term" value="P:T-helper 1 type immune response"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034142">
<property type="term" value="P:toll-like receptor 4 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0035666">
<property type="term" value="P:TRIF-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003591">
<property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000157">
<property type="entry name" value="TIR_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017241">
<property type="entry name" value="Toll-like_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR035897">
<property type="entry name" value="Toll_tir_struct_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24365">
<property type="entry name" value="PTHR24365"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Pfam" id="PF01582">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037595">
<property type="entry name" value="Toll-like_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00369">
<property type="entry name" value="LRR_TYP"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00255">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52200">
<property type="entry name" value="SSF52200"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="PROSITE" id="PS50104">
<property type="entry name" value="TIR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0913">Age-related macular degeneration</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="19">
<location>
<begin position="1"/>
<end position="23"/>
</location>
</feature>
<feature type="chain" description="Toll-like receptor 4" id="PRO_0000034722">
<location>
<begin position="24"/>
<end position="839"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="10">
<location>
<begin position="24"/>
<end position="631"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="632"/>
<end position="652"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="10">
<location>
<begin position="653"/>
<end position="839"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="55"/>
<end position="76"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="79"/>
<end position="100"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="103"/>
<end position="124"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="127"/>
<end position="148"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="151"/>
<end position="172"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="176"/>
<end position="199"/>
</location>
</feature>
<feature type="repeat" description="LRR 7">
<location>
<begin position="205"/>
<end position="225"/>
</location>
</feature>
<feature type="repeat" description="LRR 8">
<location>
<begin position="227"/>
<end position="247"/>
</location>
</feature>
<feature type="repeat" description="LRR 9">
<location>
<begin position="331"/>
<end position="351"/>
</location>
</feature>
<feature type="repeat" description="LRR 10">
<location>
<begin position="352"/>
<end position="373"/>
</location>
</feature>
<feature type="repeat" description="LRR 11">
<location>
<begin position="374"/>
<end position="394"/>
</location>
</feature>
<feature type="repeat" description="LRR 12">
<location>
<begin position="400"/>
<end position="422"/>
</location>
</feature>
<feature type="repeat" description="LRR 13">
<location>
<begin position="423"/>
<end position="444"/>
</location>
</feature>
<feature type="repeat" description="LRR 14">
<location>
<begin position="448"/>
<end position="456"/>
</location>
</feature>
<feature type="repeat" description="LRR 15">
<location>
<begin position="472"/>
<end position="495"/>
</location>
</feature>
<feature type="repeat" description="LRR 16">
<location>
<begin position="497"/>
<end position="518"/>
</location>
</feature>
<feature type="repeat" description="LRR 17">
<location>
<begin position="521"/>
<end position="542"/>
</location>
</feature>
<feature type="repeat" description="LRR 18">
<location>
<begin position="545"/>
<end position="565"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="579"/>
<end position="629"/>
</location>
</feature>
<feature type="domain" description="TIR" evidence="11">
<location>
<begin position="672"/>
<end position="815"/>
</location>
</feature>
<feature type="active site" evidence="11">
<location>
<position position="750"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17 25 32">
<location>
<position position="35"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17 25 26 32">
<location>
<position position="173"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17 25 26">
<location>
<position position="205"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17">
<location>
<position position="282"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17">
<location>
<position position="309"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17 26">
<location>
<position position="497"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17 26">
<location>
<position position="526"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17 26">
<location>
<position position="575"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17">
<location>
<position position="624"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="10">
<location>
<position position="630"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25 26">
<location>
<begin position="29"/>
<end position="40"/>
</location>
</feature>
<feature type="disulfide bond" evidence="26">
<location>
<begin position="281"/>
<end position="306"/>
</location>
</feature>
<feature type="disulfide bond" evidence="26">
<location>
<begin position="390"/>
<end position="391"/>
</location>
</feature>
<feature type="disulfide bond" evidence="26">
<location>
<begin position="583"/>
<end position="609"/>
</location>
</feature>
<feature type="disulfide bond" evidence="26">
<location>
<begin position="585"/>
<end position="627"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_035793" evidence="40">
<location>
<begin position="1"/>
<end position="200"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_035794" evidence="40 41">
<location>
<begin position="1"/>
<end position="40"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs16906079." id="VAR_021977">
<original>T</original>
<variation>A</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5030713." id="VAR_018729" evidence="16">
<original>Q</original>
<variation>R</variation>
<location>
<position position="188"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5030714." id="VAR_018730" evidence="16">
<original>C</original>
<variation>S</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_074187" evidence="36">
<original>E</original>
<variation>D</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="sequence variant" description="In allele TLR4*B; reduced LPS-response; associated with an increased risk for age-related macular degeneration in Caucasian carriers; dbSNP:rs4986790." id="VAR_012739" evidence="12 14 16 22 27">
<original>D</original>
<variation>G</variation>
<location>
<position position="299"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2770145." id="VAR_047563">
<original>C</original>
<variation>W</variation>
<location>
<position position="306"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2770144." id="VAR_047564">
<original>V</original>
<variation>G</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5030715." id="VAR_018731" evidence="16">
<original>N</original>
<variation>S</variation>
<location>
<position position="329"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5031050." id="VAR_020334">
<original>F</original>
<variation>Y</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11536884." id="VAR_037668">
<original>L</original>
<variation>F</variation>
<location>
<position position="385"/>
</location>
</feature>
<feature type="sequence variant" description="In allele TLR4*B; reduced LPS-response; dbSNP:rs4986791." id="VAR_012740" evidence="12 14 16 27">
<original>T</original>
<variation>I</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4987233." id="VAR_020335">
<original>S</original>
<variation>N</variation>
<location>
<position position="400"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5030716." id="VAR_018732" evidence="16">
<original>F</original>
<variation>L</variation>
<location>
<position position="443"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5030718." id="VAR_018733" evidence="16">
<original>E</original>
<variation>K</variation>
<location>
<position position="474"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5030719." id="VAR_018734" evidence="16">
<original>Q</original>
<variation>H</variation>
<location>
<position position="510"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5030722." id="VAR_018735" evidence="16">
<original>K</original>
<variation>R</variation>
<location>
<position position="694"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5030723." id="VAR_018736" evidence="16">
<original>R</original>
<variation>H</variation>
<location>
<position position="763"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_018737" evidence="16">
<original>Q</original>
<variation>H</variation>
<location>
<position position="834"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partially diminishes NF-kappa-B activation induced by Ni(2+). Strongly reduces NF-kappa-B activation induced by Ni(2+); when associated with A-456 or A-458." evidence="29">
<original>H</original>
<variation>A</variation>
<location>
<position position="431"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partially diminishes NF-kappa-B activation induced by Ni(2+). Strongly reduces NF-kappa-B activation induced by Ni(2+); when associated with A-431. Suppresses NF-kappa-B activation induced by Ni(2+); when associated with A-458." evidence="29">
<original>H</original>
<variation>A</variation>
<location>
<position position="456"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partially diminishes NF-kappa-B activation induced by Ni(2+). Strongly reduces NF-kappa-B activation induced by Ni(2+); when associated with A-431. Suppresses NF-kappa-B activation induced by Ni(2+); when associated with A-456." evidence="29">
<original>H</original>
<variation>A</variation>
<location>
<position position="458"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes LPS-response and prevents the cell surface expression." evidence="17">
<original>N</original>
<variation>A</variation>
<location>
<position position="526"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes LPS-response and prevents the cell surface expression." evidence="17">
<original>N</original>
<variation>A</variation>
<location>
<position position="575"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes LPS-response." evidence="13">
<original>E</original>
<variation>R</variation>
<location>
<position position="697"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes LPS-response." evidence="13">
<original>R</original>
<variation>E</variation>
<location>
<position position="710"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes LPS-response." evidence="13">
<original>D</original>
<variation>K</variation>
<location>
<position position="711"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes MYD88-binding and LPS-response." evidence="13">
<original>P</original>
<variation>H</variation>
<variation>R</variation>
<variation>E</variation>
<location>
<position position="714"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 11; ABU41664." ref="11" evidence="42">
<original>S</original>
<variation>R</variation>
<location>
<position position="73"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; BAF82742." ref="7" evidence="42">
<original>S</original>
<variation>C</variation>
<location>
<position position="400"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; BAG64706." ref="7" evidence="42">
<original>F</original>
<variation>S</variation>
<location>
<position position="581"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="29"/>
<end position="33"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="34"/>
<end position="36"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="37"/>
<end position="39"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="50"/>
<end position="52"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="58"/>
<end position="60"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="71"/>
<end position="76"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="81"/>
<end position="84"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="95"/>
<end position="100"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="106"/>
<end position="108"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="115"/>
<end position="117"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="119"/>
<end position="124"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="130"/>
<end position="132"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="141"/>
<end position="143"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="145"/>
<end position="148"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="154"/>
<end position="156"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="169"/>
<end position="173"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="179"/>
<end position="181"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="192"/>
<end position="195"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="196"/>
<end position="199"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="206"/>
<end position="209"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="220"/>
<end position="225"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="227"/>
<end position="235"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="242"/>
<end position="248"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="249"/>
<end position="252"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="254"/>
<end position="262"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="274"/>
<end position="277"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="278"/>
<end position="282"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="283"/>
<end position="292"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="295"/>
<end position="298"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="301"/>
<end position="304"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="305"/>
<end position="307"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="311"/>
<end position="317"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="319"/>
<end position="322"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="324"/>
<end position="327"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="333"/>
<end position="339"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="341"/>
<end position="344"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="355"/>
<end position="360"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="377"/>
<end position="379"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="387"/>
<end position="392"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="393"/>
<end position="396"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="403"/>
<end position="405"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="410"/>
<end position="419"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="426"/>
<end position="428"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="432"/>
<end position="437"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="438"/>
<end position="445"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="451"/>
<end position="453"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="464"/>
<end position="469"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="475"/>
<end position="477"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="484"/>
<end position="486"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="500"/>
<end position="502"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="513"/>
<end position="518"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="524"/>
<end position="526"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="538"/>
<end position="540"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="548"/>
<end position="550"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="560"/>
<end position="563"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="573"/>
<end position="575"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="585"/>
<end position="587"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="588"/>
<end position="596"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="597"/>
<end position="600"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="604"/>
<end position="606"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="608"/>
<end position="612"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="613"/>
<end position="615"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="617"/>
<end position="619"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="620"/>
<end position="622"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="627"/>
<end position="629"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="630"/>
<end position="662"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2Z62"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2Z63"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2Z66"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3FXI"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3UL8"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3UL9"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4G8A"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5NAM"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUK6"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255"/>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00204"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10835634"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11081518"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11104518"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11274165"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11514453"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11706042"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14519765"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15340161"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15356101"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15809303"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15829498"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16622205"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17478729"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17803912"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19252480"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19924287"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20037584"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20711192"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20865800"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21602844"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22363519"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23569230"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23880187"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25736436"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25787250"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27022195"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9237759"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9435236"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9435236"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000305"/>
<evidence key="43" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20711192"/>
</source>
</evidence>
<sequence length="839" mass="95680" checksum="92C48F55821133E8" modified="1998-01-01" version="2" precursor="true">MMSASRLAGTLIPAMAFLSCVRPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNITCQMNKTIIGVSVLSVLVVSVVAVLVYKFYFHLMLLAGCIKYGRGENIYDAFVIYSSQDEDWVRNELVKNLEEGVPPFQLCLHYRDFIPGVAIAANIIHEGFHKSRKVIVVVSQHFIQSRWCIFEYEIAQTWQFLSSRAGIIFIVLQKVEKTLLRQQVELYRLLSRNTYLEWEDSVLGRHIFWRRLRKALLDGKSWNPEGTVGTGCNWQEATSI</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

